{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:06:18Z","timestamp":1787065578793,"version":"build-2736575974"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T00:00:00Z","timestamp":1315785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024620","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T17:02:23Z","timestamp":1315846943000},"page":"e24620","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":90,"title":["D-\u03b2-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Soyeon","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne S.","family":"Chesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Grima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Rappold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Przedborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","article-title":"Huntington's disease - neuropathology.","volume":"100","author":"JP Vonsattel","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.","volume":"95","author":"E Brouillet","year":"2005","journal-title":"J Neurochem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.","volume":"7","author":"AG Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment.","volume":"10","author":"CA Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.","volume":"12","author":"DE Kuhl","year":"1982","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/ana.410150723","article-title":"Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.","volume":"15","author":"DE Kuhl","year":"1984","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain.","volume":"44","author":"WA Brennan Jr","year":"1985","journal-title":"J Neurochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.","volume":"17","author":"A Benchoua","year":"2006","journal-title":"Mol Biol Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease.","volume":"336","author":"VM Mann","year":"1990","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia.","volume":"41","author":"SE Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.","volume":"14","author":"IS Seong","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.","volume":"280","author":"T Milakovic","year":"2005","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.","volume":"5","author":"AV Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.","volume":"19","author":"J Kim","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.","volume":"20","author":"U Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.","volume":"17","author":"W Song","year":"2011","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","article-title":"The CBP co-activator is a histone acetyltransferase.","volume":"384","author":"AJ Bannister","year":"1996","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease.","volume":"280","author":"G Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.","volume":"23","author":"RJ Ferrante","year":"2003","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.","volume":"105","author":"EA Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","article-title":"Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington's disease.","volume":"41","author":"T Hathorn","year":"2011","journal-title":"Neurobiol Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1172\/JCI1009","article-title":"beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices.","volume":"101","author":"Y Izumi","year":"1998","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.","volume":"97","author":"Y Kashiwaya","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1471-4159.2004.02542.x","article-title":"Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats.","volume":"90","author":"ML Prins","year":"2004","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1527-3458.2005.tb00265.x","article-title":"KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.","volume":"11","author":"SL Smith","year":"2005","journal-title":"CNS Drug Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson's disease.","volume":"112","author":"K Tieu","year":"2003","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/exnr.2002.7933","article-title":"Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid.","volume":"176","author":"A Dedeoglu","year":"2002","journal-title":"Exp Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.","volume":"48","author":"MS Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.","volume":"14","author":"M Bjorkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression.","volume":"11","author":"OA Andreassen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","article-title":"Increased frequency of diabetes mellitus in patients with Huntington's chorea.","volume":"1","author":"S Podolsky","year":"1972","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.","volume":"24","author":"RJ Ferrante","year":"2004","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.","volume":"97","author":"JS Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.","volume":"291","author":"FC Nucifora Jr","year":"2001","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine.","volume":"9","author":"A McCampbell","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"44889","DOI":"10.1074\/jbc.M106575200","article-title":"The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease.","volume":"276","author":"Y Chai","year":"2001","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues.","volume":"60","author":"AM Robinson","year":"1980","journal-title":"Physiol Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(84)90034-5","article-title":"Evidence that the cytosolic activity of 3-hydroxybutyrate dehydrogenase in chicken liver is L-3-hydroxyacid dehydrogenase.","volume":"802","author":"GR Herzberg","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj1210571a","article-title":"The nature of the cytoplasmic-3-hydroxybutyrate dehydrogenase from sheep kidney.","volume":"121","author":"DH Williamson","year":"1971","journal-title":"Biochem J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj1280053","article-title":"3-hydroxybutyrate dehydrogenase in tissues from normal and ketonaemic sheep.","volume":"128","author":"HR Watson","year":"1972","journal-title":"Biochem J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1464-5491.2001.00550.x","article-title":"The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice.","volume":"18","author":"TM Wallace","year":"2001","journal-title":"Diabet Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.","volume":"27","author":"MS Levine","year":"2004","journal-title":"Trends Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.","volume":"2","author":"JY Li","year":"2005","journal-title":"NeuroRx"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington's disease: a new perspective.","volume":"62","author":"R Smith","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington's disease.","volume":"20","author":"SH Li","year":"2004","journal-title":"Trends Genet"},{"key":"ref48","first-page":"28.: 28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease.","volume":"2","author":"I Van dA","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"29.:29","DOI":"10.1186\/1471-2202-7-29","article-title":"A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis.","volume":"7","author":"Z Zhao","year":"2006","journal-title":"BMC Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.","volume":"64","author":"TB Vanitallie","year":"2005","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","article-title":"Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.","volume":"25","author":"MA Reger","year":"2004","journal-title":"Neurobiol Aging"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.1035720100","article-title":"Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake.","volume":"100","author":"RM Anson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P","article-title":"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease.","volume":"57","author":"W Duan","year":"1999","journal-title":"J Neurosci Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0405831102","article-title":"Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.","volume":"101","author":"N Maswood","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/syn.20163","article-title":"Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.","volume":"57","author":"HK Holmer","year":"2005","journal-title":"Synapse"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.","volume":"70","author":"E Brouillet","year":"1998","journal-title":"J Neurochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease.","volume":"16","author":"CT Aiken","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","article-title":"Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.","volume":"265","author":"M Yoshida","year":"1990","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.me.24.020173.001415","article-title":"Metabolism of ketone bodies by the brain.","volume":"24","author":"L Sokoloff","year":"1973","journal-title":"Annu Rev Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T09:01:55Z","timestamp":1638608515000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024620"}},"subtitle":[],"editor":[{"given":"Toshi","family":"Shioda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,12]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024620","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,12]]}}}